| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | - | 27.836 | 89.594 |
| Total Income - EUR | - | - | - | - | - | - | - | - | 27.836 | 89.594 |
| Total Expenses - EUR | - | - | - | - | - | - | - | - | 12.758 | 21.431 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | - | 15.078 | 68.163 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | - | 14.805 | 65.529 |
| Employees | - | - | - | - | - | - | - | - | 1 | 2 |
Check the financial reports for the company - Diaclinic Orl S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | - | 18.477 | 27.853 |
| Current Assets | - | - | - | - | - | - | - | - | 12.520 | 39.060 |
| Inventories | - | - | - | - | - | - | - | - | 486 | 0 |
| Receivables | - | - | - | - | - | - | - | - | 2.716 | 2.790 |
| Cash | - | - | - | - | - | - | - | - | 9.317 | 36.270 |
| Shareholders Funds | - | - | - | - | - | - | - | - | 14.816 | 64.966 |
| Social Capital | - | - | - | - | - | - | - | - | 10 | 10 |
| Debts | - | - | - | - | - | - | - | - | 16.182 | 1.947 |
| Income in Advance | - | - | - | - | - | - | - | - | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Diaclinic Orl S.r.l.